TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Setback for Bristol Myers Squibb: CheckMate -73L trial fails to meet endpoint Bristol Myers Squibb (NYSE: BMY) announced that its Phase 3 CheckMate -73L trial did not achieve its primary… byPallavi MadhirajuMay 12, 2024